Patents Assigned to Oscient Pharmaceuticals
  • Human genes of chromosome 11q13.3
    Patent number: 7151161
    Abstract: This invention relates to isolated nucleic acids comprising novel genes of a 20 cM region of human chromosome 11q13.3 and the proteins encoded by these genes. Expression vectors and host cells containing these genes or fragments thereof, as well as antibodies to the proteins encoded by these nucleic acids are also included herein.
    Type: Grant
    Filed: July 1, 2002
    Date of Patent: December 19, 2006
    Assignee: Oscient Pharmaceuticals Corporation
    Inventors: John P. Carulli, Randall D. Little, Richard Del Mastro, Mark Osborne
  • Antibacterial compounds having a (pyrrole carboxamide)-(benzamide)-(imidazole carboxamide) motif
    Patent number: 7129214
    Abstract: Compounds of the formula (I) where Ar and R are as defined herein, possess antibacterial properties.
    Type: Grant
    Filed: December 9, 2003
    Date of Patent: October 31, 2006
    Assignee: Oscient Pharmaceuticals Corporation
    Inventors: Wenhao Hu, Roland W. Bürli
  • Nucleic acid sequences relating to for diagnostics and therapeutics
    Patent number: 7090973
    Abstract: The invention provides isolated polypeptide and nucleic acid sequences derived from Bacteroides fragilis that are useful in diagnosis and therapy of pathological conditions; antibodies against the polypeptides; and methods for the production of the polypeptides. The invention also provides methods for the detection, prevention and treatment of pathological conditions resulting from bacterial infection.
    Type: Grant
    Filed: April 4, 2000
    Date of Patent: August 15, 2006
    Assignee: Oscient Pharmaceuticals Corporation
    Inventor: Gary L. Breton
  • Antibacterial compounds having a (pyrrole carboxamide)-(benzamide)-(imidazole carboxamide) motif
    Publication number: 20050004042
    Abstract: Compounds of the formula (I) where Ar and R are as defined herein, possess antibacterial properties.
    Type: Application
    Filed: December 9, 2003
    Publication date: January 6, 2005
    Applicant: Oscient Pharmaceuticals Corporation
    Inventors: Wenhao Hu, Roland Burli